Korean J Med.  2019 Feb;94(1):57-82. 10.3904/kjm.2019.94.1.57.

2018 Korean Heart Rhythm Society Guidelines for Non-Vitamin K Antagonist Oral Anticoagulants

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
  • 2Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea. mdhwp@chol.com
  • 3Division of Cardiology, Department of Internal Medicine, KyungHee University Hospital, Seou, Korea.l.
  • 4Division of Cardiology, Department of Internal Medicine, Hanyang University Seoul Hospital, Seoul, Korea.
  • 5Division of Cardiology, Department of Internal Medicine, Daegu Catholic University College of Medicine, Daeg, Korea.
  • 6Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Seoul, Korea.

Abstract

Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative to vitamin K antagonists (VKAs) and have emerged as the treatment of choice in Korea. However, several questions remain regarding the optimal use of these agents in specific clinical situations. In this paper we discuss 1) patients with atrial fibrillation (AF) and coronary artery disease, 2) avoiding confusion with NOAC dosing across indications, 3) cardioversion in a patient treated with a NOAC, 4) AF patients who present with acute stroke while on NOACs, 5) NOACs in special situations, 6) anticoagulation in AF patients with a malignancy, and 7) optimizing VKA dose adjustments.

Keyword

Atrial fibrillation; Non-vitamin K antagonist oral anticoagulants; Guideline

MeSH Terms

Anticoagulants*
Atrial Fibrillation
Coronary Artery Disease
Electric Countershock
Heart*
Humans
Korea
Stroke
Vitamin K
Anticoagulants
Vitamin K
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr